ag-1296 has been researched along with Vascular Diseases in 1 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karck, M | 1 |
| Meliss, R | 1 |
| Hestermann, M | 1 |
| Mengel, M | 1 |
| Pethig, K | 1 |
| Levitzki, A | 1 |
| Banai, S | 1 |
| Golomb, G | 1 |
| Fishbein, I | 1 |
| Chorny, M | 1 |
| Haverich, A | 1 |
1 other study available for ag-1296 and Vascular Diseases
| Article | Year |
|---|---|
Inhibition of aortic allograft vasculopathy by local delivery of platelet-derived growth factor receptor tyrosine-kinase blocker AG-1295.
Topics: Animals; Aorta; Enzyme Inhibitors; Immunohistochemistry; Male; Protein-Tyrosine Kinases; Rats; Rats, | 2002 |